本文選題：TBS　切入點(diǎn)：鱗狀上皮內(nèi)病變　出處：《中國(guó)婦產(chǎn)科臨床雜志》2017年01期

【摘要】：正TBS(The Bethesda System)子宮頸細(xì)胞學(xué)報(bào)告系統(tǒng)的應(yīng)用已經(jīng)走過近30年的歷程,其發(fā)生和發(fā)展對(duì)子宮頸細(xì)胞學(xué)乃至婦科臨床都產(chǎn)生了深遠(yuǎn)的影響。一、TBS報(bào)告系統(tǒng)的歷史回顧TBS報(bào)告系統(tǒng)創(chuàng)立于1988年,經(jīng)過了兩次改進(jìn)(TBS-1991,RBS-2001)。其目的是建立能夠提供明確管理閾值和減少觀察者間差異的報(bào)告術(shù)語。TBS-1988報(bào)告系統(tǒng)確定了對(duì)標(biāo)本滿意度評(píng)估這一重要的標(biāo)本質(zhì)量保證內(nèi)容,并推薦對(duì)于鱗狀上皮內(nèi)病變(SIL)的2級(jí)分類報(bào)告術(shù)語,即:低級(jí)別
[Abstract]:The application of positive TBS(The Bethesda system in cervical cytology report system has gone through nearly 30 years. Its occurrence and development have had a profound impact on cervical cytology and gynecologic clinic. The history of TBS reporting system was established in 1988. Two improvements have been made to TBS-1991 / RBS-2001.The aim is to establish a reporting system that provides clear management thresholds and reduces inter-observer differences. The TBS-1988 reporting system identifies an important quality assurance element for specimen satisfaction assessment. We also recommend the level 2 classification reporting terms for squamous intraepithelial lesions, I. e.
【作者單位】： 中國(guó)醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院;

【相似文獻(xiàn)】

相關(guān)重要報(bào)紙文章 前4條

1 本報(bào)記者 段沁萍;TBS電信運(yùn)營(yíng)網(wǎng)絡(luò)的強(qiáng)力支撐[N];通信產(chǎn)業(yè)報(bào);2001年

2 本報(bào)特約記者 徐靜波;日本樂天“蛇吞象”夢(mèng)難圓 拋售TBS股票[N];第一財(cái)經(jīng)日?qǐng)?bào);2008年

3 證券時(shí)報(bào)記者 李欣;邁出國(guó)際并購(gòu)第一步 中瑞思創(chuàng)擬收購(gòu)TBS[N];證券時(shí)報(bào);2011年

4 記者 陳宜萍邋通訊員 苗虎偉 史秀宏;國(guó)庫山西省分庫提高TBS運(yùn)行維護(hù)效率成效好[N];金融時(shí)報(bào);2007年

，

本文編號(hào)：1659838